Autotransfusion device market by Product Type (On-Pump Transfusion Devices, Off-Pump Transfusion Devices), by End Users (Ambulatory Surgical Centers, Hospitals, Emergency Rooms, Nursing Homes, and Others), Global Opportunity Analysis and Industry Forecast, 2019–2027
- RES4072072
- 190 Pages
- January 2020
- Healthcare
The key driving factors for the growth of the autotransfusion devices market across the globe are high occurrence of cardiac diseases, absence of any risk of transfusion & transmitted infections, and absence of any risk of alloimunization to any blood cell antigen. However, the major challenges faced by this industry is the inability to separate contaminants from blood and expensive autotransfusion system. Contrary, in the forecast period, the growing adoption of whole body autotransfusion devices.
The global autotransfusion device market is segment based on product type, End user, and region. Depending on product type the market is divided into on pump transfusion device and off pump transfusion device. Off pump transfusion device has the highest market share and is expected to grow with the a CAGR of 6.6% during the forecast period owing to ease in use coupled with the fact that there’s no loss of blood during transfusion and it is considered safer than the conventional method.
By End User, Autotransfusion device market is categorized into Ambulatory Surgical Centers, Hospitals, Emergency Rooms, Nursing Homes, and others. Hospital segment contributes the most among the end user segment. This is driven by the fact that hospitals have various specialized departments wherein blood transfusion is required as such the autotransfusion devices are required in multiple numbers to cater to various transfusion requirements of specialized symptoms coupled with the Guidelines set by the American Association of Blood Banks, the blood should be re-infused within 4 hours for washing is driving the growth of autotransfusion devices globally.
North America has the highest market share for autotransfusion device globally and is expected to grow at a healthy rate of 6.4% over the forecast period. In accordance with Guidelines set by the American Association of Blood Banks, the blood should be re-infused within 4 hours for washing. Thus pertaining to low time duration and increased demands for transfusion, more and more autotransfusion devices are being purchased by hospitals and medical institutes in North America.
U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. As the regulatory standards regarding transfusion are quite stringent in U.S., companies are investing a lot on Research & Development for approvals of commercial sale of Autotransfusion device and therefore they are focused on quality and innovative products so as to efficiently handle the process and edge ahead of competitors, thus driving the growth of Autotransfusion device in the country.
The key players analyzed in the global Autotransfusion device market Medtronic Plc, Becton Dickinson and Company, Zimmer biomet Holding, Teleflex Incorporated, LivaNova, Plc, Fresenius Medical Care AG & Co. KGaA, Stryker Corporation, Haemonetics Corporation, Terumo Corporation and Getinge AB.
KEY BENEFITS FOR STAKEHOLDERS
• This study presents the analytical depiction of the global Autotransfusion device market along with the current trends and future estimations to depict the imminent investment pockets.
• The overall market potential is determined to understand the profitable trends to enable stakeholders gain a stronger foothold in the market.
• The report presents information related to key drivers, restraints, and opportunities with a detailed impact analysis.
• The current market is quantitatively analyzed from 2018 to 2029 to highlight the financial competency of the market.
• Porter’s five forces analysis illustrates the potency of the buyers and suppliers.
Key Market Segments:
By Product Type
o On-Pump Transfusion Device
o Off-Pump Transfusion Device
By End Users
o Ambulatory Surgical Centers
o Hospitals
o Emergency Rooms
o Nursing Homes
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Russia
Rest of Europe
o Asia-Pacific
Japan
China
India
South Korea
Rest of Asia-Pacific
o LAMEA
Latin America
Middle East
Africa
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Product Type
2.3. End-User
3. Market overview
3.1. Market segmentation & definitions
3.2. Key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Market value chain analysis
3.8.1. Stress point analysis
3.9. Strategic overview
4. Autotransfusion Device Market, by Product Type
4.1. On-Pump
4.1.1. Market size and forecast, by region, 2016-2026
4.1.2. Comparative market share analysis, 2018 & 2027
4.2. Off-Pump
4.2.1. Market size and forecast, by region, 2016-2026
4.2.2. Comparative market share analysis, 2018 & 2027
5. Autotransfusion Device Market, by End-User
5.1. Ambulatory Surgical Centers
5.1.1. Market size and forecast, by region, 2016-2026
5.1.2. Comparative market share analysis, 2018 & 2027
5.2. Hospitals
5.2.1. Market size and forecast, by region, 2016-2026
5.2.2. Comparative market share analysis, 2018 & 2027
5.3. Emergency Rooms
5.3.1. Market size and forecast, by region, 2016-2026
5.3.2. Comparative market share analysis, 2018 & 2027
5.4. Nursing Homes
5.4.1. Market size and forecast, by region, 2016-2026
5.4.2. Comparative market share analysis, 2018 & 2027
5.5. Others
5.5.1. Market size and forecast, by region, 2016-2026
5.5.2. Comparative market share analysis, 2018 & 2027
6. Autotransfusion Device Market, by Region
6.1. North America
6.1.1. Market size and forecast, by product type, 2018-2027
6.1.2. Market size and forecast, by end-users, 2018-2027
6.1.3. Market size and forecast, by country, 2016-2026
6.1.4. Comparative market share analysis, 2018 & 2027
6.1.5. U.S.
6.1.5.1. Market size and forecast, by product type, 2018-2027
6.1.5.2. Market size and forecast, by end-users, 2018-2027
6.1.5.3. Comparative market share analysis, 2018 & 2027
6.1.6. Canada
6.1.6.1. Market size and forecast, by product type, 2018-2027
6.1.6.2. Market size and forecast, by end-users, 2018-2027
6.1.6.3. Comparative market share analysis, 2018 & 2027
6.1.7. Mexico
6.1.7.1. Market size and forecast, by product type, 2018-2027
6.1.7.2. Market size and forecast, by end-users, 2018-2027
6.1.7.3. Comparative market share analysis, 2018 & 2027
6.2. Europe
6.2.1. Market size and forecast, by product type, 2018-2027
6.2.2. Market size and forecast, by end-users, 2018-2027
6.2.3. Market size and forecast, by country, 2016-2026
6.2.4. Comparative market share analysis, 2018 & 2027
6.2.5. Germany
6.2.5.1. Market size and forecast, by product type, 2018-2027
6.2.5.2. Market size and forecast, by end-users, 2018-2027
6.2.5.3. Comparative market share analysis, 2018 & 2027
6.2.6. UK
6.2.6.1. Market size and forecast, by product type, 2018-2027
6.2.6.2. Market size and forecast, by end-users, 2018-2027
6.2.6.3. Comparative market share analysis, 2018 & 2027
6.2.7. France
6.2.7.1. Market size and forecast, by product type, 2018-2027
6.2.7.2. Market size and forecast, by end-users, 2018-2027
6.2.7.3. Comparative market share analysis, 2018 & 2027
6.2.8. Russia
6.2.8.1. Market size and forecast, by product type, 2018-2027
6.2.8.2. Market size and forecast, by end-users, 2018-2027
6.2.8.3. Comparative market share analysis, 2018 & 2027
6.2.9. Italy
6.2.9.1. Market size and forecast, by product type, 2018-2027
6.2.9.2. Market size and forecast, by end-users, 2018-2027
6.2.9.3. Comparative market share analysis, 2018 & 2027
6.2.10. Rest of the Europe
6.2.10.1. Market size and forecast, by product type, 2018-2027
6.2.10.2. Market size and forecast, by end-users, 2018-2027
6.2.10.3. Comparative market share analysis, 2018 & 2027
6.3. Asia-Pacific
6.3.1. Market size and forecast, by product type, 2018-2027
6.3.2. Market size and forecast, by end-users, 2018-2027
6.3.3. Market size and forecast, by country, 2016-2026
6.3.4. Comparative market share analysis, 2018 & 2027
6.3.5. China
6.3.5.1. Market size and forecast, by product type, 2018-2027
6.3.5.2. Market size and forecast, by end-users, 2018-2027
6.3.5.3. Comparative market share analysis, 2018 & 2027
6.3.6. India
6.3.6.1. Market size and forecast, by product type, 2018-2027
6.3.6.2. Market size and forecast, by end-users, 2018-2027
6.3.6.3. Comparative market share analysis, 2018 & 2027
6.3.7. Japan
6.3.7.1. Market size and forecast, by product type, 2018-2027
6.3.7.2. Market size and forecast, by end-users, 2018-2027
6.3.7.3. Comparative market share analysis, 2018 & 2027
6.3.8. South Korea
6.3.8.1. Market size and forecast, by product type, 2018-2027
6.3.8.2. Market size and forecast, by end-users, 2018-2027
6.3.8.3. Comparative market share analysis, 2018 & 2027
6.3.9. Rest of the Asia Pacific
6.3.9.1. Market size and forecast, by product type, 2018-2027
6.3.9.2. Market size and forecast, by end-users, 2018-2027
6.3.9.3. Comparative market share analysis, 2018 & 2027
6.4. LAMEA
6.4.1. Market size and forecast, by product type, 2018-2027
6.4.2. Market size and forecast, by end-users, 2018-2027
6.4.3. Market size and forecast, by country, 2016-2026
6.4.4. Comparative market share analysis, 2018 & 2027
6.4.5. Latin America
6.4.5.1. Market size and forecast, by product type, 2018-2027
6.4.5.2. Market size and forecast, by end-users, 2018-2027
6.4.5.3. Comparative market share analysis, 2018 & 2027
6.4.6. Middle East
6.4.6.1. Market size and forecast, by product type, 2018-2027
6.4.6.2. Market size and forecast, by end-users, 2018-2027
6.4.6.3. Comparative market share analysis, 2018 & 2027
6.4.7. Africa
6.4.7.1. Market size and forecast, by product type, 2018-2027
6.4.7.2. Market size and forecast, by end-users, 2018-2027
6.4.7.3. Comparative market share analysis, 2018 & 2027
7. Company profiles
7.1. Medtronic Plc
7.1.1. Business overview
7.1.2. Financial performance
7.1.3. Product portfolio
7.1.4. Recent strategic moves & developments
7.1.5. SWOT analysis
7.2. Becton Dickinson and Company
7.2.1. Business overview
7.2.2. Financial performance
7.2.3. Product portfolio
7.2.4. Recent strategic moves & developments
7.2.5. SWOT analysis
7.3. Zimmer Biomet Holding
7.3.1. Business overview
7.3.2. Financial performance
7.3.3. Product portfolio
7.3.4. Recent strategic moves & developments
7.3.5. SWOT analysis
7.4. Teleflex Incorporated
7.4.1. Business overview
7.4.2. Financial performance
7.4.3. Product portfolio
7.4.4. Recent strategic moves & developments
7.4.5. SWOT analysis
7.5. LivaNova, Plc
7.5.1. Business overview
7.5.2. Financial performance
7.5.3. Product portfolio
7.5.4. Recent strategic moves & developments
7.5.5. SWOT analysis
7.6. Fresenius Medical Care AG & Co. KGaA
7.6.1. Business overview
7.6.2. Financial performance
7.6.3. Product portfolio
7.6.4. Recent strategic moves & developments
7.6.5. SWOT analysis
7.7. Stryker Corporation
7.7.1. Business overview
7.7.2. Financial performance
7.7.3. Product portfolio
7.7.4. Recent strategic moves & developments
7.7.5. SWOT analysis
7.8. Haemonetics Corporation
7.8.1. Business overview
7.8.2. Financial performance
7.8.3. Product portfolio
7.8.4. Recent strategic moves & developments
7.8.5. SWOT analysis
7.9. Terumo Corporation
7.9.1. Business overview
7.9.2. Financial performance
7.9.3. Product portfolio
7.9.4. Recent strategic moves & developments
7.9.5. SWOT analysis
7.10. Getinge AB
7.10.1. Business overview
7.10.2. Financial performance
7.10.3. Product portfolio
7.10.4. Recent strategic moves & developments
7.10.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
